Gilcrease M Z, Delgado R, Vuitch F, Albores-Saavedra J
Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235-9073, USA.
Hum Pathol. 1998 Dec;29(12):1451-6. doi: 10.1016/s0046-8177(98)90015-6.
Because of histological similarities between nephrogenic adenomas and clear cell adenocarcinomas of the urinary tract, there is the potential for diagnostic confusion between these two entities. The histopathologic features of 13 nephrogenic adenomas and five clear cell adenocarcinomas of the urethra and urinary bladder are compared in this report, and detailed immunohistochemical staining profiles are provided for these tumors. Only 2 of the 13 nephrogenic adenomas contained clear cells, and these constituted less than 10% of the lesions. In contrast, four of the five clear cell adenocarcinomas contained prominent areas with clear cells. Nephrogenic adenomas generally showed only mild cytologic atypia, whereas four of the five clear cell adenocarcinomas showed severe atypia. A single mitotic figure was identified in only two of the nephrogenic adenomas, whereas the mitotic rate in the clear cell adenocarcinomas ranged from 2 to 14 per 10 high-power fields. None of the nephrogenic adenomas showed evidence of necrosis, but focal necrosis was noted in four of the five clear cell adenocarcinomas. In general, the nephrogenic adenomas and clear cell adenocarcinomas showed negative to weak staining with CK903 but strong staining with AE1, AE3, and Cam 5.2. Variable staining was observed with Brst-3 and antibodies to S-100, CEA (monoclonal and polyclonal), LeuM-1, and CA19.9. Nephrogenic adenomas and clear cell adenocarcinomas were all negative for prostate-specific acid phosphatase (PSAP), prostate-specific antigen (PSA), and estrogen and progesterone receptors (except for two nephrogenic adenomas, which showed only focal weak staining for estrogen receptor). Neither bcl-2 nor c-erbB-2 staining was able to discriminate between the tumors. However, strong staining for p53 was noted in each clear cell adenocarcinoma and in none of the nephrogenic adenomas. MIB-1 positivity in nephrogenic adenomas ranged from 0 to 13 (average of 5.5) per 200 cells, whereas the positive range for clear cell adenocarcinomas was 33 to 70 (average of 47) per 200 cells. In summary, histopathologic features that favor clear cell adenocarcinoma over nephrogenic adenoma include a predominance of clear cells, severe cytological atypia, high mitotic rate, necrosis, high MIB-1 positivity, and strong staining for p53.
由于肾源性腺瘤与泌尿道透明细胞腺癌在组织学上存在相似性,这两种病变在诊断上可能会产生混淆。本报告比较了13例肾源性腺瘤以及5例尿道和膀胱透明细胞腺癌的组织病理学特征,并提供了这些肿瘤详细的免疫组化染色图谱。13例肾源性腺瘤中只有2例含有透明细胞,且这些透明细胞在病变中所占比例不到10%。相比之下,5例透明细胞腺癌中有4例含有显著的透明细胞区域。肾源性腺瘤通常仅表现出轻度的细胞学异型性,而5例透明细胞腺癌中有4例表现出重度异型性。仅在2例肾源性腺瘤中发现单个有丝分裂象,而透明细胞腺癌的有丝分裂率为每10个高倍视野2至14个。所有肾源性腺瘤均未显示坏死迹象,但5例透明细胞腺癌中有4例出现局灶性坏死。总体而言,肾源性腺瘤和透明细胞腺癌对CK903呈阴性至弱阳性染色,但对AE1、AE3和Cam 5.2呈强阳性染色。观察到Brst-3以及抗S-100、CEA(单克隆和多克隆)、LeuM-1和CA19.9抗体的染色情况各不相同。肾源性腺瘤和透明细胞腺癌对前列腺特异性酸性磷酸酶(PSAP)、前列腺特异性抗原(PSA)以及雌激素和孕激素受体均呈阴性(除2例肾源性腺瘤对雌激素受体仅表现出局灶性弱阳性染色外)。bcl-2和c-erbB-2染色均无法区分这两种肿瘤。然而,在每例透明细胞腺癌中均观察到p53强阳性染色,而在所有肾源性腺瘤中均未观察到。肾源性腺瘤的MIB-1阳性率为每200个细胞0至13个(平均为5.5个),而透明细胞腺癌的阳性率范围为每200个细胞33至70个(平均为47个)。总之,相较于肾源性腺瘤,支持透明细胞腺癌的组织病理学特征包括透明细胞占优势、重度细胞学异型性、高有丝分裂率、坏死、高MIB-1阳性率以及p53强阳性染色。